Close

P2RY14 Membrane Protein Introduction

Introduction Related Products Customer Reviews Customized Production Drug Discovery

Introduction of P2RY14

Protein Name Purinergic receptor P2Y14
Gene Name P2RY14
Uniprot Q15391 (Human); Q9ESG6 (Mouse)
Synonym P2Y14; BPR105; GPR105; P2Y purinoceptor 14; G protein coupled receptor for UDP-glucose; G-protein coupled receptor 105; P2Y(14) receptor; P2Y14 receptor; UDP-glucose receptor; purinergic receptor P2Y, G-protein coupled, 14
Background P2RY14 is encoded by P2RY14 gene. It belongs to the G-protein-coupled receptor (GPCR) family which has been reported to regulate a panoply of cell signaling and physiologic responses. P2RY14 is one of the eight-member family of nucleotide-activated P2Y receptors and it is activated by UDP-glucose and other nucleotide sugars. It is also known as UDP glucose receptor because UDP glucose, UDP galactose, and UDP-N-acetylglucosamine are identified as potent agonists of P2RY14.

P2RY14 Related Products

Membrane Protein Products

Creative Biolabs offers comprehensive range of membrane protein products empowers your unique research needs.

CAT# Product Name Expression System Protein Length Solubilizing Agents
S01YF-1023-KX74 NativeExtract™ Human P2RY14 Membrane Protein (Full length, Super Nanodisc) HEK293 cell Full length Native Nanodisc
MPX3373K MemDX™ Membrane Protein Human P2RY14 Expressed in vitro E.coli expression system, Full Length E.coli cell-free Full length Detergent
MP0994X MemDX™ Membrane Protein Human P2RY14 (Purinergic receptor P2Y14) for Antibody Discovery Wheat germ cell-free Full length N/A
Please contact us for more products or customization

Customer Reviews

T***in: The tailored P2RY14 expression system delivered intact tertiary structure preservation.

08/Nov/2023

Customized Membrane Protein Production

Different membrane protein formats (Creative Biolabs Original)

P2RY14 Drug Discovery and Development

P2RY14 Small Molecule Drug Development

Small molecule drug development services (Creative Biolabs Original)

Anti-P2RY14 Antibody Discovery

Processes of antibody discovery (Creative Biolabs Original)

P2RY14 Gene Therapy Development

We provide tailored solutions to meet your specific requirements. Please inquire us for more services.

AAV-Mediated siRNA Silencing of P2RY14 in Inflammatory Pathologies

Creative Biolabs offers AAV-mediated siRNA silencing services. Recombinant adeno-associated virus (AAV) vectors engineered with small interfering RNA (siRNA) payloads enable selective downregulation of P2RY14 expression in diseased tissues. For instance, preclinical studies demonstrate that AAV9-based delivery of P2RY14-targeting siRNAs effectively attenuates intestinal epithelial cell necroptosis in murine colitis models by suppressing RIPK1 transcription via cAMP/PKA/CREB axis modulation. Creative Biolabs' expertise in designing tissue-specific AAV serotypes ensures precise transduction of colonic epithelial cells while minimizing off-target effects, a critical consideration for clinical translation.

P2RY14 Gene Editing for Hyperactivation Mitigation

Creative Biolabs offers P2RY14 gene editing services. Gene editing systems optimized for single-nucleotide precision permit permanent inactivation of gain-of-function P2RY14 mutations linked to chronic inflammation. Creative Biolabs' proprietary screening platforms validate guide RNA specificity and off-target profiles, ensuring therapeutic accuracy.

P2RY14 Cell Therapy Discovery

Creative Biolabs offers comprehensive and innovative services to drive the development of P2RY14 cell therapy. Please inquire with us for more services.

Engineered Macrophages with P2RY14 Antagonist-Secreting Capabilities

Creative Biolabs offers engineered macrophages with P2RY14 antagonist-secreting capabilities development services. Autologous macrophages genetically modified to secrete P2RY14 antagonists, such as HDL-16, offer a sustained therapeutic effect in inflamed microenvironments. These cells are transduced with lentiviral vectors encoding antagonist expression cassettes under control of hypoxia-responsive promoters, enabling localized drug release in ischemic colonic regions. Creative Biolabs' immunofluorescence-based validation services rigorously assess antagonist secretion kinetics and target engagement in 3D organoid co-culture systems.

P2RY14-Inhibitory CAR-T Cells for Immune-Mediated Disease Control

Creative Biolabs offers P2RY14-inhibitory CAR-T cells development services for immune-mediated disease control. Chimeric antigen receptor (CAR)-T cells targeting extracellular P2RY14 epitopes exhibit potent immunosuppressive activity in autoimmune disorders. By fusing a P2RY14-specific single-chain variable fragment (scFv) to intracellular NFAT signaling domains, these CAR-T cells selectively deplete P2RY14-overexpressing immune cells while sparing healthy tissues. Creative Biolabs' vector production infrastructure accelerates the transition from preclinical validation to clinical-scale manufacturing.

The complexities of P2RY14-targeted gene and cell therapies demand unparalleled technical precision. Creative Biolabs' integrated platform combines AI-driven target validation, proprietary vector engineering, and translational assay development to de-risk your drug development pipeline. Contact us to design a bespoke strategy addressing your therapeutic goals.


All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

Online Inquiry
CONTACT US
USA:
Europe:
Germany:
Call us at:
USA:
UK:
Germany:
Fax:
Email:
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2026 Creative Biolabs. | Contact Us